Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Acrobiosystems CoSZSE:301080 +7.31%92 OCF Margin % is 16.95% as of Mar. 2026, which is 17% below its 10-year median of 20.45. GuruFocus rates SZSE:301080 with a GF Score™ of 92/100 and a GF Value™ of ¥61.37 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 954 Biotechnology companies, Acrobiosystems Co ranks better than 93.08% on this metric.
The historical data trend for Acrobiosystems Co's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SZSE:301080 vs VRTX, REGN, RVMD: OCF Margin % Comparison
For the Biotechnology subindustry, Acrobiosystems Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acrobiosystems Co OCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Acrobiosystems Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Acrobiosystems Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Acrobiosystems Co (SZSE:301080) has a OCF Margin % of 16.95% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Acrobiosystems Co and its competitors. This is 17% below median its historical median of 20.45. Over the past decade, Acrobiosystems Co's OCF Margin % has ranged from 4.90 to 42.62. According to the industry distribution chart, Acrobiosystems Co ranks #66 out of 954 companies in the Biotechnology industry, placing it in the top 6.9%.
Is Acrobiosystems Co's OCF Margin % too high?
Acrobiosystems Co's current OCF Margin % of 16.95% is 17% below median its 10-year median of 20.45. Over the past 10 years, this metric has ranged from a low of 4.90 to a high of 42.62. Based on the distribution chart, Acrobiosystems Co ranks #66 out of 954 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Acrobiosystems Co has a GF Score™ of 92/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Acrobiosystems Co's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Acrobiosystems Co ranks #66 out of 954 companies for OCF Margin %. This places Acrobiosystems Co in the top 7% of its industry — outperforming the majority of peers. Historically, Acrobiosystems Co's own OCF Margin % has ranged from 4.90 to 42.62 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Acrobiosystems Co and its competitors. Acrobiosystems Co's current OCF Margin % is 16.95%, which is 17% below median its own 10-year median of 20.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acrobiosystems Co stock overvalued right now?
Based on GuruFocus' analysis, Acrobiosystems Co (SZSE:301080) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥61.37, compared to a current price of ¥88.21 — trading 43.7% above its estimated fair value. The current OCF Margin % is 16.95%, which is 17% below median its 10-year median of 20.45. Acrobiosystems Co's overall GF Score™ is 92/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Acrobiosystems Co (SZSE:301080), the current OCF Margin % is 16.95% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Acrobiosystems Co (SZSE:301080) Overvalued in 2026?
Based on GuruFocus' analysis, Acrobiosystems Co stock appears to be overvalued.
The current stock price of ¥88.21 is trading 43.7% above its estimated GF Value™ of ¥61.37.
GuruFocus considers Acrobiosystems Co to be Significantly Overvalued.
Key valuation signals for SZSE:301080:
OCF Margin %: 16.95% (17% below median its 10-year median of 20.45)
GF Value™: ¥61.37 vs. price of ¥88.21 (43.7% above fair value)
No single metric tells the full story. See the SZSE:301080 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Acrobiosystems Co Ltd is a global brand focusing on protein technology, products and services in the development of biological drugs. It is committed to providing target antigens and other key reagents and related services required in the development of targeted therapeutic drugs.
92GF Score
Get the complete analysis for SZSE:301080
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:301080 has been successfully added to your 
